The SDF-1 3'A genetic variation is correlated with elevated intra-tumor tissue and circulating concentration of cxcl12 in glial tumors: A study on iranian anaplastic astrocytoma and glioblastoma multiforme patients

Journal of Molecular Neuroscience

Volumn 50, Issue 2, 2013, Pages 298-304

  Moosavi, Seyyed Reza ^a   Khorramdelazad, Hossein ^b   Amin, Masoud ^b   Fatahpoor, Shirin ^b   Moogooei, Mozhgan ^b   Karimabad, Mojgan Noroozi ^b   Paghale, Mohamadreza Jamali ^b   Vakilian, Alireza ^b   Hassanshahi, Gholamhossein ^b  

^a KERMAN UNIVERSITY OF MEDICAL SCIENCES   (Iran)

^b RAFSANJAN UNIVERSITY OF MEDICAL SCIENCES   (Iran)

Author keywords

Anaplastic astrocytoma; Chemokine; CXCL12; Glioblastoma multiforme; Polymorphism

Indexed keywords

STROMAL CELL DERIVED FACTOR 1;

ADULT; ALLELE; ARTICLE; BLOOD SAMPLING; DENSITOMETRY; DNA POLYMORPHISM; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; GENETIC ASSOCIATION; GENETIC VARIABILITY; GENOTYPE; GLIOBLASTOMA; HUMAN; MAJOR CLINICAL STUDY; MALE; QUESTIONNAIRE; TUMOR BIOPSY; WESTERN BLOTTING;

ADULT; ASTROCYTOMA; BRAIN NEOPLASMS; CASE-CONTROL STUDIES; CHEMOKINE CXCL12; FEMALE; GLIOBLASTOMA; HUMANS; IRAN; MALE; MIDDLE AGED; POLYMORPHISM, SINGLE NUCLEOTIDE;

EID: 84878230128     PISSN: 08958696     EISSN: 15591166     Source Type: Journal    
DOI: 10.1007/s12031-013-9954-2     Document Type: Article

References (35)

1. Azin H, Vazirinejad R, Ahmadabadi BN, Khorramdelazad H, Zarandi ER, Arababadi MK et al (2011) The SDF-1 3'A genetic variation of the chemokine SDF-1alpha (CXCL12) in parallel with its increased circulating levels is associated with susceptibility to MS: a study on Iranian multiple sclerosis patients. J Mol Neurosci 29:29
2. Bajetto A, Bonavia R, Barbero S, Piccioli P, Costa A, Florio T et al (1999) Glial and neuronal cells express functional chemokine receptor CXCR4 and its natural ligand stromal cell-derived factor 1. J Neurochem 73(6):2348-2357
3. Bajetto A, Bonavia R, Barbero S, Florio T, Schettini G (2001a) Chemokines and their receptors in the central nervous system. Front Neuroendocrinol 22(3):147-184
4. Bajetto A, Barbero S, Bonavia R, Piccioli P, Pirani P, Florio T et al (2001b) Stromal cell-derived factor-1alpha induces astrocyte proliferation through the activation of extracellular signal-regulated kinases 1/2 pathway. J Neurochem 77(5):1226-1236
5. Bajetto A, Bonavia R, Barbero S, Schettini G (2002) Characterization of chemokines and their receptors in the central nervous system: physiopathological implications. J Neurochem 82(6):1311-1329
6. Barbero S, Bajetto A, Bonavia R, Porcile C, Piccioli P, Pirani P et al (2002) Expression of the chemokine receptor CXCR4 and its ligand stromal cell-derived factor 1 in human brain tumors and their involvement in glial proliferation in vitro. Ann N Y Acad Sci 973:60-69
7. Barbero S, Bonavia R, Bajetto A, Porcile C, Pirani P, Ravetti JL et al (2003) Stromal cell-derived factor 1alpha stimulates human glioblastoma cell growth through the activation of both extracellular signal-regulated kinases 1/2 and Akt. Cancer Res 63(8):1969-1974
8. Burger JA, Peled A (2009) CXCR4 antagonists: targeting the microenvironment in leukemia and other cancers. Leukemia 23(1):43-52, Epub 2008 Nov 6
9. Busillo JM, Benovic JL (2007) Regulation of CXCR4 signaling. Biochim Biophys Acta 1768(4):952-963, Epub 2006 Nov 10
10. Christopherson K 2nd, Hromas R (2001) Chemokine regulation of normal and pathologic immune responses. Stem Cells 19(5):388-396
11. Ehtesham M, Winston JA, Kabos P, Thompson RC (2006) CXCR4 expression mediates glioma cell invasiveness. Oncogene 25(19):2801-2806
12. Fulton AM (2009) The chemokine receptors CXCR4 and CXCR3 in cancer. Curr Oncol Rep 11(2):125-131
13. Furnari FB, Fenton T, Bachoo RM, Mukasa A, Stommel JM, Stegh A et al (2007) Malignant astrocytic glioma: genetics, biology, and paths to treatment. Genes Dev 21(21):2683-2710
14. Gonzalo JA, Lloyd CM, Peled A, Delaney T, Coyle AJ, Gutierrez-Ramos JC (2000) Critical involvement of the chemotactic axis CXCR4/stromal cell-derived factor-1 alpha in the inflammatory component of allergic airway disease. J Immunol 165(1):499-508
15. Hess DC, Borlongan CV (2008) Cell-based therapy in ischemic stroke. Expert Rev Neurother 8(8):1193-1201
16. Kantele JM, Kurk S, Jutila MA (2000) Effects of continuous exposure to stromal cell-derived factor-1 alpha on T cell rolling and tight adhesion to monolayers of activated endothelial cells. J Immunol 164(10):5035-5040
17. Leonardi A (2002) Vernal keratoconjunctivitis: pathogenesis and treatment. Prog Retin Eye Res 21(3):319-339
18. Li M, Ransohoff RM (2008) Multiple roles of chemokine CXCL12 in the central nervous system: a migration from immunology to neurobiology. Prog Neurobiol 84(2):116-131, Epub 2007 Nov 26
19. Loetscher P, Gong JH, Dewald B, Baggiolini M, Clark-Lewis I (1998) N-terminal peptides of stromal cell-derived factor-1 with CXC chemokine receptor 4 agonist and antagonist activities. J Biol Chem 273(35):22279-22283
20. Maher EA, Furnari FB, Bachoo RM, Rowitch DH, Louis DN, Cavenee WK et al (2001) Malignant glioma: genetics and biology of a grave matter. Genes Dev 15(11):1311-1333
21. Nanki T, Lipsky PE (2000) Cutting edge: stromal cell-derived factor-1 is a costimulator for CD4+ T cell activation. J Immunol 164(10):5010-5014
22. Oh JW, Drabik K, Kutsch O, Choi C, Tousson A, Benveniste EN (2001) CXC chemokine receptor 4 expression and function in human astroglioma cells. J Immunol 166(4):2695-2704
23. Pedeboscq S, L'Azou B, Liguoro D, Pometan JP, Cambar J (2007) Interindividual differences in anticancer drug cytotoxicity in primary human glioblastoma cells. Exp Toxicol Pathol 58(4):247-253, Epub 2006 Nov 22
24. Peng SB, Peek V, Zhai Y, Paul DC, Lou Q, Xia X et al (2005) Akt activation, but not extracellular signal-regulated kinase activation, is required for SDF-1alpha/CXCR4-mediated migration of epitheloid carcinoma cells. Mol Cancer Res 3(4):227-236
25. Redjal N, Chan JA, Segal RA, Kung AL (2006) CXCR4 inhibition synergizes with cytotoxic chemotherapy in gliomas. Clin Cancer Res 12(22):6765-6771
26. Rempel SA, Dudas S, Ge S, Gutierrez JA (2000) Identification and localization of the cytokine SDF1 and its receptor, CXC chemokine receptor 4, to regions of necrosis and angiogenesis in human glioblastoma. Clin Cancer Res 6(1):102-111
27. Robinson DS, Hamid Q, Jacobson M, Ying S, Kay AB, Durham SR (1993) Evidence for Th2-type T helper cell control of allergic disease in vivo. Springer Semin Immunopathol 15(1):17-27
28. Rubin JB, Kung AL, Klein RS, Chan JA, Sun Y, Schmidt K et al (2003) A small-molecule antagonist of CXCR4 inhibits intracranial growth of primary brain tumors. Proc Natl Acad Sci U S A 100(23):13513-13518, Epub 2003 Oct 31
29. Sehgal A, Keener C, Boynton AL, Warrick J, Murphy GP (1998a) CXCR-4, a chemokine receptor, is overexpressed in and required for proliferation of glioblastoma tumor cells. J Surg Oncol 69(2):99-104
30. Sehgal A, Ricks S, Boynton AL, Warrick J, Murphy GP (1998b) Molecular characterization of CXCR-4: a potential brain tumor-associated gene. J Surg Oncol 69(4):239-248
31. Sozzani S, Luini W, Borsatti A, Polentarutti N, Zhou D, Piemonti L et al (1997) Receptor expression and responsiveness of human dendritic cells to a defined set of CC and CXC chemokines. J Immunol 159(4):1993-2000
32. Stevenson CB, Ehtesham M, McMillan KM, Valadez JG, Edgeworth ML, Price RR et al (2008) CXCR4 expression is elevated in glioblastoma multiforme and correlates with an increase in intensity and extent of peritumoral T2-weighted magnetic resonance imaging signal abnormalities. Neurosurgery 63(3):560-569, discussion 9-70
33. Wen PY, Kesari S (2008) Malignant gliomas in adults. N Engl J Med 359(5):492-507
34. Xie K (2001) Interleukin-8 and human cancer biology. Cytokine Growth Factor Rev 12(4):375-391
35. Zhou Y, Larsen PH, Hao C, Yong VW (2002) CXCR4 is a major chemokine receptor on glioma cells and mediates their survival. J Biol Chem 277(51):49481-49487, Epub 2002 Oct 17